Low levels of TIGAR increased the production of lipid peroxidation and promoted the accumulation of lipid peroxidation product malondialdehyde (MDA), but no significant change was observed in iron levels, suggesting that TIGAR is a potential target for ferroptosis-based CRC treatment by regulating ROS 50. The gene discussed is TIGAR; the disease is colorectal carcinoma.